{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:06:21Z","timestamp":1791860781408,"version":"4.3.4"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T00:00:00Z","timestamp":1553644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"DOI":"10.3389\/fnins.2019.00255","type":"journal-article","created":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T04:16:09Z","timestamp":1553660169000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["Tremor-Dominant in Parkinson Disease: The Relevance to Iron Metabolism and Inflammation"],"prefix":"10.3389","volume":"13","author":[{"given":"Teng-Hong","family":"Lian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Jun","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Yang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu-Jin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Dan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,3,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1017\/cjn.2015.328","article-title":"Parkinson disease: the relationship between non-motor symptoms and motor phenotype.","volume":"43","author":"Ba","year":"2016","journal-title":"Can. J. Neurol. Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s11910-012-0283-6","article-title":"Neuroinflammation and non-motor symptoms: the dark passenger of Parkinson\u2019s disease?","volume":"12","author":"Barnum","year":"2012","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"B3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrn2038","article-title":"Microglia-mediated neurotoxicity: uncovering the molecular mechanisms.","volume":"8","author":"Block","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0304-3940(95)12192-7","article-title":"Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer\u2019s and de novo Parkinson\u2019s disease patients.","volume":"202","author":"Blum-Degen","year":"1995","journal-title":"Neurosci. Lett."},{"key":"B5","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1093\/aje\/kwm260","article-title":"Peripheral inflammatory biomarkers and risk of Parkinson\u2019s disease.","volume":"167","author":"Chen","year":"2008","journal-title":"Am. J. Epidemiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1182\/blood-2009-11-253815","article-title":"Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway.","volume":"116","author":"Cohen","year":"2010","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1016\/j.neuropharm.2012.01.028","article-title":"Contributions of central and systemic inflammation to the pathophysiology of Parkinson\u2019s disease.","volume":"62","author":"Collins","year":"2012","journal-title":"Neuropharmacology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/S0887-8994(01)00303-4","article-title":"Iron and iron management proteins in neurobiology.","volume":"25","author":"Connor","year":"2001","journal-title":"Pediatr. Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.parkreldis.2015.07.006","article-title":"Haptoglobin phenotype modifies serum iron levels and the effect of smoking on Parkinson disease risk.","volume":"21","author":"Costa-Mallen","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.autrev.2016.07.022","article-title":"Parkinson\u2019s disease: autoimmunity and neuroinflammation.","volume":"15","author":"De Virgilio","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/mds.27001","article-title":"Tau\/alpha-synuclein ratio and inflammatory proteins in Parkinson\u2019s disease: An exploratory study.","volume":"32","author":"Delgado-Alvarado","year":"2017","journal-title":"Mov. Disord."},{"key":"B12","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/S0301-0082(97)00021-X","article-title":"Interleukin-6 (IL-6)\u2013a molecule with both beneficial and destructive potentials.","volume":"52","author":"Gadient","year":"1997","journal-title":"Prog. Neurobiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1002\/jmri.25434","article-title":"Influence of regional iron on the motor impairments of Parkinson\u2019s disease: a quantitative susceptibility mapping study.","volume":"45","author":"Guan","year":"2017","journal-title":"J. Magn. Reson. Imaging"},{"key":"B14","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/0005-2728(96)00022-9","article-title":"The ferritins: molecular properties, iron storage function and cellular regulation.","volume":"1275","author":"Harrison","year":"1996","journal-title":"Biochim. Biophys. Acta"},{"key":"B15","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/mds.27224","article-title":"The cerebral basis of Parkinsonian tremor: a network perspective.","volume":"33","author":"Helmich","year":"2018","journal-title":"Mov. Disord."},{"key":"B16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/ana.22361","article-title":"Pallidal dysfunction drives a cerebellothalamic circuit into Parkinson tremor.","volume":"69","author":"Helmich","year":"2011","journal-title":"Ann. Neurol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"12212","DOI":"10.1021\/bi961235j","article-title":"Fe2+, Fe3+, and oxygen react with DNA-derived radicals formed during iron-mediated Fenton reactions.","volume":"35","author":"Henle","year":"1996","journal-title":"Biochemistry"},{"key":"B18","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/s1474-4422(09)70062-6","article-title":"Neuroinflammation in Parkinson\u2019s disease: a target for neuroprotection?","volume":"8","author":"Hirsch","year":"2009","journal-title":"Lancet Neurol."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138997","article-title":"Investigation on abnormal iron metabolism and related inflammation in Parkinson disease patients with probable RBD.","volume":"10","author":"Hu","year":"2015","journal-title":"PLoS One"},{"key":"B20","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases.","volume":"55","author":"Hughes","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2011.00179","article-title":"A role for locus coeruleus in Parkinson tremor.","volume":"5","author":"Isaias","year":"2011","journal-title":"Front. Hum. Neurosci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41577-018-0066-7","article-title":"Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer.","volume":"18","author":"Jones","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.clineuro.2018.01.022","article-title":"Increased serum levels of TNF-alpha and decreased serum levels of IL-27 in patients with Parkinson disease and their correlation with disease severity.","volume":"166","author":"Kouchaki","year":"2018","journal-title":"Clin. Neurol. Neurosurg."},{"key":"B24","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1039\/c4mt00164h","article-title":"Iron regulatory proteins and their role in controlling iron metabolism.","volume":"7","author":"Kuhn","year":"2015","journal-title":"Metallomics"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-14721-1","article-title":"Iron deposition in substantia nigra: abnormal iron metabolism, neuroinflammatory mechanism and clinical relevance.","volume":"7","author":"Liu","year":"2017","journal-title":"Sci. Rep."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1007\/s11064-012-0729-x","article-title":"Serum iron, vitamin B12 and folic acid levels in Parkinson\u2019s disease.","volume":"37","author":"Madenci","year":"2012","journal-title":"Neurochem. Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1176\/appi.psy.51.6.474","article-title":"The role of inflammatory cytokines in cognition and other non-motor symptoms of Parkinson\u2019s disease.","volume":"51","author":"Menza","year":"2010","journal-title":"Psychosomatics"},{"key":"B28","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1177\/1533317517714887","article-title":"Frontal tasks and behavior in rigid or tremor-dominant Parkinson disease.","volume":"32","author":"Moretti","year":"2017","journal-title":"Am. J. Alzheimers Dis. Other Demen."},{"key":"B29","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s10534-012-9550-x","article-title":"Iron deficiency on neuronal function.","volume":"25","author":"Munoz","year":"2012","journal-title":"Biometals"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.3109\/10715762.2012.697626","article-title":"Melatonin attenuated mediators of neuroinflammation and alpha-7 nicotinic acetylcholine receptor mRNA expression in lipopolysaccharide (LPS) stimulated rat astrocytoma cells, C6.","volume":"46","author":"Niranjan","year":"2012","journal-title":"Free Radic. Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/s1474-4422(11)70143-0","article-title":"Freezing of gait: moving forward on a mysterious clinical phenomenon.","volume":"10","author":"Nutt","year":"2011","journal-title":"Lancet Neurol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1159\/000342140","article-title":"Dopamine agonists upregulate IL-6 and IL-8 production in human keratinocytes.","volume":"19","author":"Parrado","year":"2012","journal-title":"Neuroimmunomodulation"},{"key":"B33","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jns.2016.09.030","article-title":"IL-6 serum levels are elevated in Parkinson\u2019s disease patients with fatigue compared to patients without fatigue.","volume":"370","author":"Pereira","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-10593-7","article-title":"Restless legs syndrome in Parkinson disease: Clinical characteristics, abnormal iron metabolism and altered neurotransmitters.","volume":"7","author":"Piao","year":"2017","journal-title":"Sci. Rep."},{"key":"B35","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1053\/shem.2002.35638","article-title":"Rare causes of hereditary iron overload.","volume":"39","author":"Ponka","year":"2002","journal-title":"Semin. Hematol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1196\/annals.1306.022","article-title":"Hereditary causes of disturbed iron homeostasis in the central nervous system.","volume":"1012","author":"Ponka","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1212\/wnl.0000000000004078","article-title":"Baseline motor findings and Parkinson disease prognostic subtypes.","volume":"89","author":"Rajput","year":"2017","journal-title":"Neurology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1212\/01.wnl.0000285082.18969.3a","article-title":"Globus pallidus dopamine and Parkinson motor subtypes: clinical and brain biochemical correlation.","author":"Rajput","year":"2008","journal-title":"Neurology"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00234","article-title":"Association between peripheral inflammation and DATSCAN data of the striatal nuclei in different motor subtypes of Parkinson disease.","volume":"9","author":"Sanjari Moghaddam","year":"2018","journal-title":"Front. Neurol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S1353-8020(99)00051-6","article-title":"Parkinson\u2019s disease subtypes: clinical classification and ventricular cerebrospinal fluid analysis.","volume":"6","author":"Schiess","year":"2000","journal-title":"Parkinsonism Relat. Disord."},{"key":"B41","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1146\/annurev-pathol-011110-130242","article-title":"Parkinson\u2019s disease: genetics and pathogenesis.","volume":"6","author":"Shulman","year":"2011","journal-title":"Annu. Rev. Pathol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1111\/j.1471-4159.2010.07132.x","article-title":"The relevance of iron in the pathogenesis of Parkinson\u2019s disease.","volume":"118","author":"Sian-Hulsmann","year":"2011","journal-title":"J. Neurochem."},{"key":"B43","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.parkreldis.2017.08.029","article-title":"Quantitative susceptibility mapping differentiates between parkinsonian disorders.","volume":"44","author":"Sjostrom","year":"2017","journal-title":"Parkinsonism Relat. Disord."},{"key":"B44","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1001\/jamaneurol.2013.6233","article-title":"Parkinson disease subtypes.","volume":"71","author":"Thenganatt","year":"2014","journal-title":"JAMA Neurol."},{"key":"B45","doi-asserted-by":"crossref","first-page":"71","DOI":"10.31887\/DCNS.2017.19.1\/rpal","article-title":"The potential role of neuroinflammation and transcription factors in Parkinson disease.","volume":"19","author":"Tiwari","year":"2017","journal-title":"Dialogues Clin. Neurosci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/jnc.12244","article-title":"Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cells.","volume":"126","author":"Urrutia","year":"2013","journal-title":"J. Neurochem."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2014.00038","article-title":"The interplay between iron accumulation, mitochondrial dysfunction, and inflammation during the execution step of neurodegenerative disorders.","volume":"5","author":"Urrutia","year":"2014","journal-title":"Front. Pharmacol."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-019-02730-7","article-title":"Dopamine alters lipopolysaccharide-induced nitric oxide production in microglial cells via activation of D1-like receptors.","author":"Wang","year":"2019","journal-title":"Neurochem. Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1177\/0891988716632918","article-title":"Excessive iron and alpha-synuclein oligomer in brain are relevant to pure apathy in Parkinson disease.","volume":"29","author":"Wang","year":"2016","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.freeradbiomed.2013.01.017","article-title":"Targeting dysregulation of brain iron homeostasis in Parkinson\u2019s disease by iron chelators.","volume":"62","author":"Weinreb","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1002\/mds.26563","article-title":"Serum immune markers and disease progression in an incident Parkinson\u2019s disease cohort (ICICLE-PD).","volume":"31","author":"Williams-Gray","year":"2016","journal-title":"Mov. Disord."},{"key":"B52","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.parkreldis.2017.08.013","article-title":"Different iron deposition patterns in early- and middle-late-onset Parkinson\u2019s disease.","volume":"44","author":"Xuan","year":"2017","journal-title":"Parkinsonism Relat. Disord."},{"key":"B53","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1001\/archneur.1969.00480160015001","article-title":"Treatment of parkinsonism with levodopa.","volume":"21","author":"Yahr","year":"1969","journal-title":"Arch. Neurol."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-018-1016-5","article-title":"Clinical features and dysfunctions of iron metabolism in Parkinson disease patients with hyper echogenicity in substantia nigra: a cross-sectional study.","volume":"18","author":"Yu","year":"2018","journal-title":"BMC Neurol."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0082924","article-title":"Sleep disorders in Parkinson\u2019s disease: clinical features, iron metabolism and related mechanism.","volume":"8","author":"Yu","year":"2013","journal-title":"PLoS One"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s12035-013-8586-4","article-title":"Role and mechanism of microglial activation in iron-induced selective and progressive dopaminergic neurodegeneration.","volume":"49","author":"Zhang","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-016-0018-z","article-title":"Serotonergic dysfunctions and abnormal iron metabolism: Relevant to mental fatigue of Parkinson disease.","volume":"6","author":"Zuo","year":"2016","journal-title":"Sci. Rep."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2019.00255\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T00:06:04Z","timestamp":1607040364000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2019.00255\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,27]]},"references-count":57,"alternative-id":["10.3389\/fnins.2019.00255"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2019.00255","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,27]]},"article-number":"255"}}